atorvastatin lipitor patent
The patent (EP 409,281) had been challenged by generics manufacturer Ranbaxy and expires in July 2010. And global patent rights for the use of statin drugs atorvastatin lipitor patent for the prevention and treatment of Alzheimer's disease, the leading cause of dementia in the elderly, afflicting an estimated 4. 5 atorvastatin lipitor patent million people in the U. Larry Sparks at the Sun Health Research Institute in Arizona found evidence that a daily dose of atorvastatin (Lipitor(R)) could help slow the progressive deterioration of mental function and behavior usually found in mild to moderate Alzheimer's disease patients.
Of Federal atorvastatin lipitor patent district Court in Delaware ruled that two patents protecting atorvastatin, the active ingredient in Lipitor, are valid. In addition to recent studies presented at major medical conferences, published peer-reviewed studies include, for example, International Journal of Geriatric Psychiatry 2004; 19:327-32; Neuroepidemiology 2004; 23:94-8; Neuron 2004; 41:7-10; Arch Neurol 2000; 57:1439-1443; Lancet 2000; 356:1627-1631; Arch Neurol 2002; 59:223-227; J Gerontol Biol Sci Med Sci 2002;57:M414-M418; and J Am atorvastatin lipitor patent geriatr Soc 2002;50:1852-1856. Physicians are increasingly aware of the potential use atorvastatin lipitor patent of statins for Alzheimer's disease.
This court decision is consistent with the fundamental principle that patent laws exist to support and encourage medical innovators, not undermine them, Pfizer chairman and CEO Hank McKinnell said in a statement. Ruling atorvastatin lipitor patent from this because of the different legal standards.Prudential Equity Group Inc. Nymox has a number of drugs in development for Alzheimer's disease, oncology, and infectious disease. In October, a British court ruled one of Pfizer's British patents on Lipitor invalid, although it upheld another. Edwards & Sons Inc. Atorvastatin lipitor patent, notes that the case isn't the only issue facing Lipitor. Decision on Lipitor's patents will go, but that his legal consultants expect Pfizer to win on the critical active ingredient patent.
James Frederick Category Specialist NEW YORK -- Pfizer Inc said today that the Court of Appeal of The Hague in the Netherlands has ruled that the basic patent covering atorvastatin - the active ingredient in Lipitor - would be infringed by a competitor product from generics manufacturer Ranbaxy. CLIA-certified test to aid in the diagnosis of Alzheimer's disease. Meanwhile, health plan Wellpoint Inc. The Company also has several hundred patents and patent atorvastatin lipitor patent applications.
How To Make Codeine
Comments (14)robert | Thursday 26th February 2009 06:45:17 AM
Next year, two other cholesterol lowering drugs lose patent protection, and there is concern that Lipitor sales growth may sputter Atorvastatin lipitor patent as managed care companies push the cheaper, generic versions of those medicines.tara | Monday 23rd March 2009 01:39:36 AM
For pharmacists, while generic atorvastatin may be a boon for pharmacy margins, the atorvastatin lipitor patent transfer of $7. 4 billion from the branded drug market to the generics arena would spell a significant downturn in same-store pharmacy sales.
Atorvastatin lipitor patent new YORK -- Pfizer Inc.
mitch | Friday 13th March 2009 06:18:44 AM
The Company has successfully completed atorvastatin lipitor patent two U.
mark | Friday 20th March 2009 10:13:46 PM
The decision -- which resulted from a patent challenge by generic manufacturers Ranbaxy Laboratories Limited and Basics GmbH -- has no immediate commercial impact because neither company has regulatory approval to sell a generic atorvastatin product in Germany, and because Pfizer's basic patent covering atorvastatin remains in force, and expires atorvastatin lipitor patent after the enantiomer patent.
luna | Thursday 5th March 2009 12:19:09 AM
Judge Nicholas Pumfrey upheld the patent covering atorvastatin, Lipitor's active ingredient, but ruled that atorvastatin lipitor patent another patent was invalid.
robert | Wednesday 18th March 2009 11:32:45 PM
The patent at issue in the lawsuit (EP 409,281) expires in July 2010.
spec | Thursday 19th March 2009 02:56:53 AM
Pfizer said it will continue to vigorously Atorvastatin lipitor patent defend its patents against infringement. Supplier News -- Pfizer may be able to maintain the patents protecting the best-selling pharmaceutical in the world following a atorvastatin lipitor patent federal judge ruling last month against Ranbaxy Laboratories.